@article{2df62546a6334523b28949a1f0d7b973,
title = "Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: An observational study",
author = "Shamir Geller and Myskowski, {Patricia L.}",
note = "Funding Information: From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Dr. Geller also is from the Division of Dermatology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Israel. Dr. Myskowski also is from Weill Cornell Medicine, New York. The authors report no conflict of interest. This study was funded in part through the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. The funding institutions were not involved in the study design, data collection, data analysis, manuscript preparation, or publication decisions. Correspondence: Shamir Geller, MD, Dermatology Service, Memorial Sloan Kettering Cancer Center, 16 E 60th St, New York, NY 10022 (shamirgeller@gmail.com).",
year = "2020",
month = may,
language = "אנגלית",
volume = "105",
pages = "E27--E32",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "5",
}